Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment

Introduction: Creatine Kinase (CK), a key enzyme of cellular energy metabolism helps the cells to function under high demands by involving in contractile processes and active trans-membrane transport by readily providing Adenosine-5’- triphosphate (ATP). Higher CK activity increases cardiovascular t...

Full description

Bibliographic Details
Main Authors: Surankita Sukul, Jyotirmayee Bahinipati, Saurav Patra, Kandasamy Ravichandran
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2018-11-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/12284/36908_CE[Ra1]_F(SL)_PF1(A_SHU).pdf
_version_ 1811299505150099456
author Surankita Sukul
Jyotirmayee Bahinipati
Saurav Patra
Kandasamy Ravichandran
author_facet Surankita Sukul
Jyotirmayee Bahinipati
Saurav Patra
Kandasamy Ravichandran
author_sort Surankita Sukul
collection DOAJ
description Introduction: Creatine Kinase (CK), a key enzyme of cellular energy metabolism helps the cells to function under high demands by involving in contractile processes and active trans-membrane transport by readily providing Adenosine-5’- triphosphate (ATP). Higher CK activity increases cardiovascular trophic responses and development of arterial hypertension. Hence, high CK activity may increase hypertension risk and may also be a cause behind the hypertensive treatment failure. Aim: In the present study, serum CK levels are compared between hypertensive and normotensive study subjects and association of serum CK in hypertensive treatment failure cases. Materials and Methods: A total of 75 known hypertensive patients who were under antihypertensive treatment for ≥3 months were taken as cases. Further grouping of the patients was done based upon the response to antihypertensive treatment into treatment control (n=40) and without treatment control (n=35) groups. Forty individuals age and sex matched normotensive control were taken. Serum Creatine Kinase, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, was measured in the study group. Kruskal Wallis test was done to compare the parameters in all the three study groups. Correlation of serum CK with other parameters was done. Cut-Off value for serum CK was calculated in hypertensive cases. Results: CK was found to be higher in hypertensive cases with treatment control (99.55±31.34) U/L compared to normotensives (72.66±25.42) U/L. Significantly higher CK level was found in hypertensive treatment failures (313.92±133.12) U/L compared to treatment control cases. Statistically significant correlation was found between serum CK with SBP and DBP in hypertensive treatment failure cases. A cut-off value of 168.5 U/L was found out in hypertensive patients. Conclusion: Serum CK was found to be associated with severity of blood pressure and failure of antihypertensive therapy.
first_indexed 2024-04-13T06:36:49Z
format Article
id doaj.art-b44660fd83d445609d0c21c56dc46cbd
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-13T06:36:49Z
publishDate 2018-11-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-b44660fd83d445609d0c21c56dc46cbd2022-12-22T02:57:53ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2018-11-011211BC19BC2210.7860/JCDR/2018/36908.12284Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive TreatmentSurankita Sukul0Jyotirmayee Bahinipati1Saurav Patra2Kandasamy Ravichandran3Tutor, Department of Biochemistry, IQ City Medical College, Durgapur, West Bengal, India.Associate Professor, Department of Biochemistry, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.Consultant, Department of Biochemistry, Apollo Hospital, Bhubaneswar, Odisha, India.Associate Professor, Department of Statistics, PIMS, Puducherry, India.Introduction: Creatine Kinase (CK), a key enzyme of cellular energy metabolism helps the cells to function under high demands by involving in contractile processes and active trans-membrane transport by readily providing Adenosine-5’- triphosphate (ATP). Higher CK activity increases cardiovascular trophic responses and development of arterial hypertension. Hence, high CK activity may increase hypertension risk and may also be a cause behind the hypertensive treatment failure. Aim: In the present study, serum CK levels are compared between hypertensive and normotensive study subjects and association of serum CK in hypertensive treatment failure cases. Materials and Methods: A total of 75 known hypertensive patients who were under antihypertensive treatment for ≥3 months were taken as cases. Further grouping of the patients was done based upon the response to antihypertensive treatment into treatment control (n=40) and without treatment control (n=35) groups. Forty individuals age and sex matched normotensive control were taken. Serum Creatine Kinase, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, was measured in the study group. Kruskal Wallis test was done to compare the parameters in all the three study groups. Correlation of serum CK with other parameters was done. Cut-Off value for serum CK was calculated in hypertensive cases. Results: CK was found to be higher in hypertensive cases with treatment control (99.55±31.34) U/L compared to normotensives (72.66±25.42) U/L. Significantly higher CK level was found in hypertensive treatment failures (313.92±133.12) U/L compared to treatment control cases. Statistically significant correlation was found between serum CK with SBP and DBP in hypertensive treatment failure cases. A cut-off value of 168.5 U/L was found out in hypertensive patients. Conclusion: Serum CK was found to be associated with severity of blood pressure and failure of antihypertensive therapy.https://jcdr.net/articles/PDF/12284/36908_CE[Ra1]_F(SL)_PF1(A_SHU).pdfblood pressurebody mass indexcreatine kinase
spellingShingle Surankita Sukul
Jyotirmayee Bahinipati
Saurav Patra
Kandasamy Ravichandran
Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment
Journal of Clinical and Diagnostic Research
blood pressure
body mass index
creatine kinase
title Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment
title_full Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment
title_fullStr Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment
title_full_unstemmed Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment
title_short Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment
title_sort serum creatine kinase activity among hypertensive patients and its role as a predictor for failure of antihypertensive treatment
topic blood pressure
body mass index
creatine kinase
url https://jcdr.net/articles/PDF/12284/36908_CE[Ra1]_F(SL)_PF1(A_SHU).pdf
work_keys_str_mv AT surankitasukul serumcreatinekinaseactivityamonghypertensivepatientsanditsroleasapredictorforfailureofantihypertensivetreatment
AT jyotirmayeebahinipati serumcreatinekinaseactivityamonghypertensivepatientsanditsroleasapredictorforfailureofantihypertensivetreatment
AT sauravpatra serumcreatinekinaseactivityamonghypertensivepatientsanditsroleasapredictorforfailureofantihypertensivetreatment
AT kandasamyravichandran serumcreatinekinaseactivityamonghypertensivepatientsanditsroleasapredictorforfailureofantihypertensivetreatment